Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar 7:15:23.
doi: 10.1186/1472-6939-15-23.

Life context of pharmacological academic performance enhancement among university students--a qualitative approach

Affiliations

Life context of pharmacological academic performance enhancement among university students--a qualitative approach

Elisabeth Hildt et al. BMC Med Ethics. .

Abstract

Background: Academic performance enhancement or cognitive enhancement (CE) via stimulant drug use has received increasing attention. The question remains, however, whether CE solely represents the use of drugs for achieving better academic or workplace results or whether CE also serves various other purposes. The aim of this study was to put the phenomenon of pharmacological academic performance enhancement via prescription and illicit (psycho-) stimulant use (Amphetamines, Methylphenidate) among university students into a broader context. Specifically, we wanted to further understand students' experiences, the effects of use on students and other factors, such as pressure to perform in their academic and private lives.

Methods: A sample of 18 healthy university students reporting the non-medical use of prescription and illicit stimulants for academic performance enhancement was interviewed in a face-to-face setting. The leading questions were related to the situations and context in which the students considered the non-medical use of stimulants.

Results: Based on the resultant transcript, two independent raters identified six categories relating to the life context of stimulant use for academic performance enhancement: Context of stimulant use beyond academic performance enhancement, Subjective experience of enhancement, Timing of consumption, Objective academic results, Side effects, Pressure to perform.

Conclusions: The answers reveal that academic performance enhancement through the use of stimulants is not an isolated phenomenon that solely aims at enhancing cognition to achieve better academic results but that the multifaceted life context in which it is embedded is of crucial relevance. The participants not only considered the stimulants advantageous for enhancing academic performance, but also for leading an active life with a suitable balance between studying and time off. The most common reasons given for stimulant use were to maximize time, to increase motivation and to cope with memorizing. According to the interviews, there is a considerable discrepancy between subjective experiences and objective academic results achieved.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Procedure of building categories for analysis.

Similar articles

Cited by

References

    1. Partridge BJ, Bell SK, Lucke JC, Yeates S, Hall WD. Smart drugs “as common as coffee”: media hype about neuroenhancement. PLoS One. 2011;6:e28416. doi: 10.1371/journal.pone.0028416. - DOI - PMC - PubMed
    1. de Jongh R, Bolt I, Schermer M, Olivier B. Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neurosci Biobehav Rev. 2008;32:760–776. doi: 10.1016/j.neubiorev.2007.12.001. - DOI - PubMed
    1. Maher B. Poll results: look who’s doping. Nature. 2008;452:674–675. doi: 10.1038/452674a. - DOI - PubMed
    1. Franke AG, Lieb K. In: Cognitive Enhancement - An Interdisciplinary Perspective. Hildt E, Franke AG, editor. Heidelberg: Springer Verlag; 2013. Pharmacological Neuroenhancement: Substances and Epidemiology; pp. 17–27.
    1. Repantis D, Schlattmann P, Laisney O, Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res. 2010;62:187–206. doi: 10.1016/j.phrs.2010.04.002. - DOI - PubMed

Publication types